Operative management of multilevel iliofemoral occlusive disease

Division of Cardiothoracic Surgery, University of Kentucky, Lexington, Kentucky, USA.
International Journal of Angiology 09/2009; 18(3):135-6. DOI: 10.1055/s-0031-1278340
Source: PubMed


The current trend is to treat both inflow and outflow occlusive disease using endovascular procedures either simultaneously or in a staged procedure. The long-term benefits of a combined one-stage approach are not available.
The main objectives are to investigate the risks and long-term benefits of a combined one-stage approach using endovascular techniques for iliac occlusive disease and bypass for femoropopliteal occlusive disease.
Fifty-three patients with limb ischemia underwent combined ilial stenting and distal bypass. Complications included minor wound problems in nine patients, atrial fibrillations in one patient, acute graft occlusion in one patient, toe amputation in two patients and one death. During a follow-up period of up to 96 months, eight patients required repeat distal bypass, five patients underwent revascularization on contralateral sides and four patients had repeat endovascular procedures.
These results suggest that there are few risks with a combined endovascular procedure for iliac occlusion and bypass for femoropopliteal occlusive disease. Long-term complications with the combined approach included repeat distal bypass, revascularization on contralateral sides and repeat endovascular procedure.

Download full-text


Available from: Sibu Saha, Sep 12, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The presence of peripheral vascular disease along with coronary heart disease are the two components of generalized atherosclerosis. The risk of having one when the other is present is extremely high. There are four parts to consider in peripheral vascular disease management and these are prevention, plaque stabilization, percutaneous intervention and surgery. Each part has its place but no one would argue that prevention is best when risk is recognized and treated. Classic risk factors and the available diagnostic methods are discussed. Treatment of risk factors is presented with reduction of the low density lipoproteins as the established gold standard during the current era. Procedures of percutaneous vascular intervention with their procedural indications are presented and their advantages and disadvantages discussed. Surgical indications are presented with special indication due to major claudication, rest pain, or tissue loss. Prognosis is also considered and this prognosis is worse in more proximal peripheral vascular disease. Association with other diseases is an important part of prognosis, with the latter especially made worse by the presence of diabetes mellitus. Surprisingly, the long-term prognosis of peripheral vascular disease is worse than that of coronary heart disease. These patients have a significant increase of cardiovascular risk factors and of comorbidities. It has been shown that these patients are undertreated in spite of their high cardiovascular risk. It is mandatory that they receive the same intensive treatment of risk factors as that given to coronary heart disease patients.
    No preview · Article · Mar 2011 · Cardiovascular & hematological agents in medicinal chemistry